Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Molecules ; 29(15)2024 Aug 03.
Article in English | MEDLINE | ID: mdl-39125089

ABSTRACT

Nerve agents are organophosphates (OPs) that act as potent inhibitors of acetylcholinesterase (AChE), the enzyme responsible for the hydrolysis of acetylcholine. After inhibition, a dealkylation reaction of the phosphorylated serine, known as the aging of AChE, can occur. When aged, reactivators of OP-inhibited AChE are no longer effective. Therefore, the realkylation of aged AChE may offer a pathway to reverse AChE aging. In this study, molecular modeling was conducted to propose new ligands as realkylators of aged AChE. We applied a methodology involving docking and quantum mechanics/molecular mechanics (QM/MM) calculations to evaluate the resurrection kinetic constants and ligand interactions with OP-aged AChE, comparing them to data found in the literature. The results obtained confirm that this method is suitable for predicting kinetic and thermodynamic parameters of ligands, which can be useful in the design and selection of new and more effective ligands for AChE realkylation.


Subject(s)
Acetylcholinesterase , Cholinesterase Inhibitors , Indolequinones , Acetylcholinesterase/chemistry , Acetylcholinesterase/metabolism , Cholinesterase Inhibitors/chemistry , Cholinesterase Inhibitors/pharmacology , Kinetics , Indolequinones/chemistry , Molecular Docking Simulation , Ligands , Thermodynamics , Models, Molecular , Humans , Molecular Dynamics Simulation
2.
Int J Mol Sci ; 21(18)2020 Sep 05.
Article in English | MEDLINE | ID: mdl-32899591

ABSTRACT

Organophosphorus (OP) compounds are used as both chemical weapons and pesticides. However, these agents are very dangerous and toxic to humans, animals, and the environment. Thus, investigations with reactivators have been deeply developed in order to design new antidotes with better efficiency, as well as a greater spectrum of action in the acetylcholinesterase (AChE) reactivation process. With that in mind, in this work, we investigated the behavior of trimedoxime toward the Mus musculus acetylcholinesterase (MmAChE) inhibited by a range of nerve agents, such as chemical weapons. From experimental assays, reactivation percentages were obtained for the reactivation of different AChE-OP complexes. On the other hand, theoretical calculations were performed to assess the differences in interaction modes and the reactivity of trimedoxime within the AChE active site. Comparing theoretical and experimental data, it is possible to notice that the oxime, in most cases, showed better reactivation percentages at higher concentrations, with the best result for the reactivation of the AChE-VX adduct. From this work, it was revealed that the mechanistic process contributes most to the oxime efficiency than the interaction in the site. In this way, this study is important to better understand the reactivation process through trimedoxime, contributing to the proposal of novel antidotes.


Subject(s)
Cholinesterase Reactivators/chemistry , Trimedoxime/pharmacology , Trimedoxime/therapeutic use , Acetylcholinesterase/metabolism , Animals , Antidotes/pharmacology , Cholinesterase Inhibitors/metabolism , Cholinesterase Inhibitors/pharmacology , Cholinesterase Reactivators/pharmacology , Computational Biology/methods , Humans , Mice , Nerve Agents/chemistry , Organophosphorus Compounds/chemistry , Oximes/chemistry , Rats
3.
Chem Biol Interact ; 309: 108671, 2019 Aug 25.
Article in English | MEDLINE | ID: mdl-31207225

ABSTRACT

Studies with oximes have been extensively developed to design new reactivators with better efficiency, and greater spectrum of action. In this study, we aimed to analyze the influence of the Carbamoyl group position change in two isomeric oximes, K203 and K206, on the reactivation percentage of Mus musculus Acetylcholinesterase (MmAChE), inhibited by different nerve agents. Theoretical calculations were performed to assess the difference for the oxime activity with inhibited AChE-complexes and the factors that govern this difference. Comparing theoretical and experimental data, it is possible to observe that this change between the oximes results in different reactivation percentage for the same nerve agent, due to the different interaction modes and activation energy for the studied systems.


Subject(s)
Acetylcholinesterase/metabolism , Cholinesterase Reactivators/chemistry , Organophosphorus Compounds/chemistry , Oximes/chemistry , Acetylcholinesterase/chemistry , Animals , Binding Sites , Cholinesterase Reactivators/metabolism , Drug Design , Mice , Molecular Docking Simulation , Nerve Agents/chemistry , Nerve Agents/metabolism , Organophosphorus Compounds/metabolism , Organothiophosphorus Compounds/chemistry , Organothiophosphorus Compounds/metabolism , Quantum Theory , Thermodynamics
4.
J Biomol Struct Dyn ; 35(6): 1272-1282, 2017 May.
Article in English | MEDLINE | ID: mdl-27125569

ABSTRACT

Butyryl cholinesterase (BChE) has been seen as a key enzyme in the search for new strategies in the treatment of poisoning by organophosphates (OPs), since human BChE (HssBChE), complexed with the appropriate oxime, can be a suitable scavenger and deactivator for OPs in the blood stream. However, the efficacy of HssBChE is limited by its strict stoichiometric scavenging, slow reactivation, and propensity for aging. The improvement of the reactivation rate by new and more efficient oximes could contribute to mitigate this problem and increase the HssBChE efficiency as scavenger. Several oximes have been synthesized and tested with this goal, some with promising results, but the mechanistic aspects of the reactivation reaction are not fully understood yet. In order to better investigate this mechanism, docking and mixed quantum and molecular mechanics combined with principal components analysis were performed here to evaluate the capacity of reactivation and determine the preferred route for the reactivation reaction of two new oximes on HssBChE inhibited by the neurotoxic agents cyclosarin and sarin. Plots of potential energies were calculated and all the transition states of the reactional mechanism were determined. Our results showed a good correlation with experimental data and pointed to the most efficient oxime with both OPs. The protocol used could be a suitable tool for a preliminary evaluation of the HssBChE reactivation rates by new oximes.


Subject(s)
Butyrylcholinesterase/chemistry , Cholinesterase Inhibitors/chemistry , Cholinesterase Reactivators/chemistry , Organophosphorus Compounds/chemistry , Oximes/chemistry , Sarin/chemistry , Cholinesterase Inhibitors/pharmacology , Cholinesterase Reactivators/pharmacology , Humans , Models, Chemical , Models, Molecular , Organophosphorus Compounds/pharmacology , Oximes/pharmacology , Protein Binding , Sarin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL